Bioquell expects revenues for the year ended 31 Dec to be ahead of its previous forecasts at approximately £29.3m (2016: £26.8m)
It said this estimate comprised £28.6m for the biodecontamination business (2016: £25.2m), representing growth of some 13% (9.6% at constant currency rates) and £0.7m for the defence business (2016: £1.3m), where revenues fluctuate significantly from year to year.
It said pre-exceptional earnings before tax were expected to be significantly ahead of market expectations.
It said that as previously announced, an exceptional gain of £0.25m would be recognised on the disposal of the Airflow business.
The company had net cash of £14.5m at the year end.
The preliminary results for the year ended 31 Dec will be announced on 7 Mar.
At 9:03am: (LON:BQE) Bioquell PLC share price was +28p at 310p